Your browser doesn't support javascript.
loading
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol.
Tan, Ngoc H; Sablerolles, Roos S G; Rietdijk, Wim J R; Goorhuis, Abraham; Postma, Douwe F; Visser, Leo G; Bogers, Susanne; Geers, Daryl; Zaeck, Luca M; Koopmans, Marion P G; Dalm, Virgil A S H; Kootstra, Neeltje A; Huckriede, Anke L W; van Baarle, Debbie; Lafeber, Melvin; GeurtsvanKessel, Corine H; de Vries, Rory D; van der Kuy, Paul-Hugo Marie.
Affiliation
  • Tan NH; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands.
  • Sablerolles RSG; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands.
  • Rietdijk WJR; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands.
  • Goorhuis A; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Postma DF; Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, Netherlands.
  • Visser LG; Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, Netherlands.
  • Bogers S; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Geers D; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Zaeck LM; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Koopmans MPG; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Dalm VASH; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Kootstra NA; Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Huckriede ALW; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
  • van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Lafeber M; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • GeurtsvanKessel CH; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • de Vries RD; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
  • van der Kuy PM; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
Front Immunol ; 13: 1067749, 2022.
Article in En | MEDLINE | ID: mdl-36524126
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Country of publication: